03/21/2024 5:19 PM | Busque Philippe (Reporting) Cytek Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 7:27 PM | Cytek Biosciences (Issuer) McCombe William D. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
03/19/2024 5:25 PM | Cytek Biosciences (Issuer) Yan Ming (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/18/2024 3:35 PM | Cytek Biosciences (Subject) Yan Ming (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/13/2024 5:53 PM | Cytek Biosciences (Issuer) Williams Paul Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 5:55 PM | Cytek Biosciences (Issuer) Yan Ming (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 5:44 PM | Cytek Biosciences (Issuer) Jeanmonod Patrik (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
03/13/2024 5:48 PM | Cytek Biosciences (Issuer) Jiang Wenbin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 5:50 PM | Cytek Biosciences (Issuer) Poirson Allen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 5:39 PM | Barnett Valerie (Reporting) Cytek Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 3:42 PM | Cytek Biosciences (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/08/2024 5:44 PM | Barnett Valerie (Reporting) Cytek Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 5:46 PM | Busque Philippe (Reporting) Cytek Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 5:47 PM | Cytek Biosciences (Issuer) Jiang Wenbin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 5:49 PM | Cytek Biosciences (Issuer) Poirson Allen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 5:51 PM | Cytek Biosciences (Issuer) Williams Paul Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 5:52 PM | Cytek Biosciences (Issuer) Yan Ming (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 3:05 PM | Cytek Biosciences (Filer)
| Form NT 10-K | |
03/01/2024 5:06 AM | Cytek Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/27/2024 5:06 AM | Cytek Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/22/2024 6:07 PM | Cytek Biosciences (Subject) RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G | |
02/22/2024 4:37 PM | Barnett Valerie (Reporting) Cytek Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/22/2024 4:46 PM | Cytek Biosciences (Issuer) Jiang Wenbin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/22/2024 4:49 PM | Cytek Biosciences (Issuer) Williams Paul Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/22/2024 4:50 PM | Cytek Biosciences (Issuer) Yan Ming (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/22/2024 4:32 PM | Cytek Biosciences (Issuer) Poirson Allen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/22/2024 4:34 PM | Cytek Biosciences (Issuer) Jeanmonod Patrik (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 2:12 PM | BROWN CAPITAL MANAGEMENT LLC (Filed by) Cytek Biosciences (Subject)
| Form SC 13G | |
01/23/2024 3:13 PM | BlackRock Inc. (Filed by) Cytek Biosciences (Subject)
| Form SC 13G/A | |
01/09/2024 5:05 AM | Cytek Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/27/2023 4:36 PM | Cytek Biosciences (Issuer) Jeanmonod Patrik (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/21/2023 4:35 PM | Cytek Biosciences (Issuer) Yan Ming (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/19/2023 3:28 PM | Cytek Biosciences (Subject) Yan Ming (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/28/2023 6:00 AM | Cytek Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/27/2023 7:48 PM | Cytek Biosciences (Issuer) Yan Ming (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/27/2023 7:53 PM | Cytek Biosciences (Issuer) Jeanmonod Patrik (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2023 4:56 PM | Cytek Biosciences (Issuer) Williams Paul Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2023 4:59 PM | Cytek Biosciences (Issuer) Yan Ming (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2023 4:46 PM | Barnett Valerie (Reporting) Cytek Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2023 4:48 PM | Cytek Biosciences (Issuer) Jiang Wenbin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2023 4:52 PM | Cytek Biosciences (Issuer) Jeanmonod Patrik (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
AI to Meet the Same Fate as EVs? (Ad) When these tech bubbles burst, they invariably leave investors disillusioned by their losses.
Now, many worry a similar fate is awaiting AI.
And one man, legendary financial analyst Porter Stansberry, who called Nvidia at $11… Simply click here to read Porter’s warning on The Big AI Die-Up now. |
11/21/2023 4:54 PM | Cytek Biosciences (Issuer) Poirson Allen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/14/2023 3:39 PM | Cytek Biosciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/09/2023 5:06 AM | Cytek Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/08/2023 5:03 PM | Cytek Biosciences (Issuer) Jiang Wenbin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/07/2023 3:45 PM | Cytek Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/25/2023 5:29 PM | Cytek Biosciences (Issuer) Jeanmonod Patrik (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/23/2023 7:36 PM | Cytek Biosciences (Issuer) Yan Ming (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/19/2023 3:02 PM | Cytek Biosciences (Subject) Yan Ming (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/11/2023 6:25 PM | Cytek Biosciences (Issuer) Jiang Wenbin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/05/2023 7:32 PM | Cytek Biosciences (Issuer) Jiang Wenbin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/26/2023 5:42 PM | Cytek Biosciences (Issuer) Jeanmonod Patrik (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/20/2023 5:27 PM | Cytek Biosciences (Issuer) Yan Ming (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/19/2023 4:25 PM | Cytek Biosciences (Subject) RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
09/08/2023 6:12 PM | Cytek Biosciences (Issuer) Jiang Wenbin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/07/2023 3:15 PM | Cytek Biosciences (Subject) Jiang Wenbin (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/29/2023 5:01 PM | Busque Philippe (Reporting) Cytek Biosciences (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
08/28/2023 4:37 PM | Cytek Biosciences (Issuer) Jeanmonod Patrik (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/21/2023 7:16 PM | Cytek Biosciences (Issuer) Williams Paul Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/21/2023 7:19 PM | Cytek Biosciences (Issuer) Jiang Wenbin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/21/2023 7:21 PM | Cytek Biosciences (Issuer) Jeanmonod Patrik (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/21/2023 7:08 PM | Cytek Biosciences (Issuer) Yan Ming (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/21/2023 7:10 PM | Cytek Biosciences (Issuer) Garland Jonathan Todd (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/21/2023 7:12 PM | Cytek Biosciences (Issuer) Poirson Allen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/21/2023 7:14 PM | Barnett Valerie (Reporting) Cytek Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/21/2023 3:20 PM | Cytek Biosciences (Subject) Yan Ming (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/08/2023 7:30 PM | Cytek Biosciences (Issuer) Jiang Wenbin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/25/2023 5:22 PM | Cytek Biosciences (Issuer) Jeanmonod Patrik (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/24/2023 3:03 PM | Cytek Biosciences (Subject) Jeanmonod Patrik (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/20/2023 5:19 PM | Cytek Biosciences (Issuer) Yan Ming (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/07/2023 7:48 PM | Cytek Biosciences (Issuer) Jiang Wenbin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2023 6:06 PM | Cytek Biosciences (Issuer) Jeanmonod Patrik (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2023 5:29 PM | Cytek Biosciences (Issuer) Yan Ming (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2023 3:29 PM | Cytek Biosciences (Subject) Yan Ming (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/20/2023 5:12 AM | Cytek Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/16/2023 5:41 PM | Cytek Biosciences (Issuer) NEFF DEBORAH J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 5:34 PM | Ball Jack (Reporting) Cytek Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 5:36 PM | Cytek Biosciences (Issuer) Dion Gisele (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 5:38 PM | Cytek Biosciences (Issuer) HARDISON DON M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 5:39 PM | Cytek Biosciences (Issuer) Imper Vera (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2023 5:52 PM | Cytek Biosciences (Issuer) Jiang Wenbin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/25/2023 4:42 PM | Cytek Biosciences (Issuer) Jeanmonod Patrik (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/19/2023 7:09 PM | Cytek Biosciences (Issuer) Yan Ming (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/19/2023 5:54 PM | Cytek Biosciences (Issuer) Poirson Allen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/19/2023 6:02 PM | Cytek Biosciences (Issuer) Garland Jonathan Todd (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/19/2023 6:08 PM | Cytek Biosciences (Issuer) Jiang Wenbin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/19/2023 6:11 PM | Cytek Biosciences (Issuer) Jeanmonod Patrik (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/19/2023 6:17 PM | Cytek Biosciences (Issuer) Williams Paul Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/19/2023 6:18 PM | Barnett Valerie (Reporting) Cytek Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2023 3:03 PM | Cytek Biosciences (Filer)
| Form 8-K/A | |
05/10/2023 6:08 PM | Cytek Biosciences (Issuer) Jiang Wenbin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
AI to Meet the Same Fate as EVs? (Ad) When these tech bubbles burst, they invariably leave investors disillusioned by their losses.
Now, many worry a similar fate is awaiting AI.
And one man, legendary financial analyst Porter Stansberry, who called Nvidia at $11… Simply click here to read Porter’s warning on The Big AI Die-Up now. |
05/08/2023 3:22 PM | Cytek Biosciences (Subject) Jiang Wenbin (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/05/2023 10:52 AM | BlackRock Inc. (Filed by) Cytek Biosciences (Subject)
| Form SC 13G/A | |
04/28/2023 3:08 PM | Cytek Biosciences (Filer)
| Form DEF 14A | |
04/28/2023 3:10 PM | Cytek Biosciences (Filer)
| Form DEFA14A | |
04/28/2023 3:11 PM | Cytek Biosciences (Filer)
| Form ARS | |
04/25/2023 5:43 PM | Cytek Biosciences (Issuer) Jeanmonod Patrik (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/24/2023 3:21 PM | Cytek Biosciences (Subject) Jeanmonod Patrik (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/20/2023 4:50 PM | Cytek Biosciences (Issuer) Yan Ming (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/19/2023 3:16 PM | Cytek Biosciences (Subject) Yan Ming (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |